Coralmyn, also called Polyvalent Anti-coral Fabotherapic, is a
polyclonal
Polyclonal B cell response is a natural mode of immune response exhibited by the adaptive immune system of mammals. It ensures that a single antigen is recognized and attacked through its overlapping parts, called epitopes, by multiple clones ...
antivenom
Antivenom, also known as antivenin, venom antiserum, and antivenom immunoglobulin, is a specific treatment for envenomation. It is composed of antibodies and used to treat certain venomous bites and stings. Antivenoms are recommended only if ...
F(ab')
2 used to treat venomous bites in mammals from the
eastern coral snake and the
Texas coral snake
''Micrurus tener'', commonly known as the Texas coral snake, is a species of venomous snake in the family Elapidae. The species is endemic to the southern United States and northeastern and central Mexico. Five subspecies are recognized as bei ...
. It was manufactured in Mexico by the ''
Instituto Bioclon
The Instituto Bioclon S.A. de C.V. (Bioclon Institute) was formed in 1990 to research and develop F(ab’)2 antivenoms. On May 6, 2015 they received approval from the FDA to commercialize Anavip becoming their second drug approved by the FDA aft ...
'', and was only obtainable in the United States with an application of an USDA importer's permit and state license. Because of the relative rarity of such bites, the remaining United States reserve of this medicine has been restricted to human-only use and is set to expire in 2017. Treatment of small animals (dogs and cats) with this product following accidental bites had proven highly effective in preventing shock and death.
References
{{reflist
Antitoxins